Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|3|209-215

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.3, 2007-05, pp. : 209-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimer's Disease

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1389-1397

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease

By Medina Miguel   Avila Jesús  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

Glycogen synthase kinase-3 – a promising therapeutic target: interview with Hagit Eldar-Finkelman

By Quigley Emma  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 199-201

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 665-679

Bentham Science Publishers

Access to resources Recommend Favorite

Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 281-290

Bentham Science Publishers

Access to resources Recommend Favorite